Myosin IH anticorps (AA 1002-1014)

N° du produit ABIN1804780

Cet anticorps Chèvre Polyclonal détecte spécifiquement Myosin IH dans WB, ELISA, IHC (p) et IHC. Il présente une réactivité avec des échantillons de Humain et Souris.

Aperçu rapide pour Myosin IH anticorps (AA 1002-1014) (ABIN1804780)

Antigène: Myosin IH (MYO1H)

Reactivité: Humain, Souris

Hôte: Chèvre

Clonalité: Polyclonal

Conjugué: Cet anticorp Myosin IH est non-conjugé

Application: Western Blotting (WB), ELISA, Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (IHC)

Détail du produit anti-Myosin IH anticorps

Épitope: AA 1002-1014

Specificité: MYO1H

Purification: Immunoaffinity purified

Immunogène: Synthetic peptide C-EDQVYKDKNGQLR from the C-terminus of mouse MYO1H (NP_001158045.1).

Type of Immunogen: Synthetic peptide

Information d'application

Indications d'application: Approved: IHC, IHC-P (5 μg/mL), Peptide-ELISA (1:128000), WB (0.1 - 0.3 μg/mL)

Usage: Peptide ELISA: antibody detection limit dilution 1:128000. Western blot: Approx 110kD band observed in lysates of cell line NIH3T3 (calculated MW of 118kD according to NP_001158045.1). Recommended concentration: 0.1-0.3 μg/mL. An additional band of unknown identity was also consistently observed at 28kD. This band was successfully blocked by incubation with the immunizing peptide.

Commentaires:

Target Species of Antibody: Mouse

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: Lot specific

Buffer: Tris-buffered saline,  pH 7.3, 0.5 % BSA, 0.02 % sodium azide

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Avoid repeated freezing and thawing.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Avoid freeze-thaw cycles.

Détails sur Myosin IH

Antigène: Myosin IH (MYO1H)

Autre désignation: MYO1H

Sujet: Name/Gene ID: MYO1H

Synonyms: MYO1H

ID gène: 283446

NCBI Accession: NP_001158045